HCLTech has joined the Microsoft Discovery Platform, an advanced agentic AI system built to accelerate breakthroughs in science and engineering. As one of a select group of technology leaders and research institutions, HCLTech is helping pioneer next-generation innovation in drug discovery, materials science, semiconductor design and clean energy.

Our partnership integrates HCLTech’s domain expertise in life sciences, healthcare and engineering with Microsoft’s cutting-edge agentic AI, cloud infrastructure and high-performance computing capabilities. Together, we are enabling enterprises to run large-scale simulations, automate complex scientific workflows and shorten the path from hypothesis to validated discovery.

The collaboration accelerates industry adoption of Microsoft’s next-generation R&D vision, delivered at enterprise scale. HCLTech’s role focuses on enabling practical enterprise use cases, developing advanced AI agents and driving platform adoption across industries.

R&D trends for today and tomorrow

HCLTech’s integration with the Discovery Platform reflects the latest R&D trends, including the shift from isolated tools to AI-orchestrated research workflows and the growing adoption of multi-agent systems. These advances dramatically accelerate cycles from hypothesis generation to validation, transforming the pace of discovery.

Furthermore, it empowers R&D teams with natural language-driven research orchestration, improving accessibility and reducing manual effort in experimentation and analysis. This approach moves beyond traditional tools toward fully orchestrated, AI-driven research environments—replacing isolated experiments with continuous, intelligent discovery cycles.

HCLTech’s impact: Advancing Azure Quantum Elements and agentic AI for life sciences and health

Microsoft Discovery Platform and Azure Quantum Elements work together as an AI and high-performance computing (HPC)-driven Discovery Platform stack. Discovery Platform helps scientists explore hypotheses and candidate materials or molecules, while Azure Quantum Elements, a specialized chemistry, pharmaceutical and materials science focused layer built on top of the Azure Quantum platform, provides the cloud infrastructure and scientific computing workflows behind that exploration. Scientists are enabled to explore many more candidate molecules and materials, run simulations faster and eventually benefit from quantum computing for harder problems.

HCLTech and Microsoft are accelerating life sciences and healthcare (LSH) R&D by integrating Azure Quantum Elements with agentic AI. This partnership goes beyond classical computational limits to address complex molecular and genomic challenges.

HCLTech contributions include:

• Designing and deploying autonomous, domain-specific AI agents that orchestrate end-to-end scientific workflows—from hypothesis generation to digital synthesis.
• Integrating enterprise data with Azure Quantum and the Discovery Platform.
• Identifying and onboarding pilot use cases in:
  • Drug Discovery: Novel small molecules and lead optimization to reduce wet-lab iterations.
  • Materials Science: Biocompatible materials and stable formulations for better drug delivery.
  • Genomics: Faster secondary analysis of large-scale sequencing data.
  • Clinical Trials: Synthetic data generation to optimize protocols and minimize patient risk.
• Co-innovating with Microsoft on validation and scaling.
• Implementing Azure HPC infrastructure with quantum-ready algorithms for current and future workloads.
• Applying AI-driven insights to massive biological datasets for personalized medicine and advanced protein analysis.

Why HCLTech? A Proven Strategic Partner

Microsoft selected HCLTech as a strategic partner due to its strong track record of delivering AI and engineering solutions within the Microsoft ecosystem, combined with deep industry knowledge in life sciences and healthcare.

HCLTech operates a dedicated AI Center of Excellence featuring advanced multi-agent RAG (Retrieval-Augmented Generation) systems.

In this setup, specialized agents collaborate intelligently: a planner decomposes complex R&D questions, retrievers source relevant data, extractors validate facts, generators synthesize insights and a manager oversees the entire workflow. This architecture delivers superior accuracy, traceability and adaptability for sophisticated scientific tasks.

“HCLTech is a natural choice to help expand the Microsoft Discovery platform and the development of sustainable, innovative solutions,” said Aseem Datar, Corporate Vice President, Product Innovation, Microsoft Discovery Platform and Quantum.

Delivering Value for Clients and the Industry

This partnership bridges the gap between groundbreaking ideas and scalable delivery. Clients gain faster scientific innovation, reduced data friction and a competitive edge across industries.

By delivering sustainable enterprise-read solutions built on the Microsoft Discovery Platform and Azure Quantum Elements, HCLTech helps organizations transform R&D productivity while preparing for the quantum era.

For more details, visit the official HCLTech announcement. This marks a significant step toward agentic AI-powered scientific discovery at enterprise scale.